|
|
|
|
| TRADING CENTER |
37.67-0.01 / -0.03%
Sanofi Aventis (NYSE:SNY)
37.700.03 / 0.08
After hours quote
Prev. Close:
37.68
Open:
37.21
High:
37.69
Low:
37.11
Volume:
1,097,500
Volume Avg.:
1,539,400
52wk Range:
23.95 - 40.17
Market Cap (mil):
99,159.57
P/E Ratio:
20.25
Dividend Yield:
N/A
| Cramer's 'Mad Money' Recap: Next Week's Game Plan (Update 2) - at TheStreet.com | |
| Pozen Initiates New Phase III - Analyst Blog - Zacks.com | |
| AstraZeneca Seeks FDA Approval - Analyst Blog - Zacks.com | |
| 4-Star Stocks Poised to Pop: Merck - MotleyFool.com | |
| Pfizer Dodges a Bullet - MotleyFool.com | |
| AstraZeneca bets on a blood drug with multibillion-dollar potential - DailyFinance | |
| New GoMeals(TM) iPhone Application from sanofi-aventis U.S. to Help People with Diabe... - PR Newswire | |
| Beacon Equity Issues Technical Trading Overview for Questcor Pharmaceuticals Inc. - GlobeNewswire | |
| 5 Stocks Making Cash - MotleyFool.com | |
| Dividends for 100 Years - MotleyFool.com | |
| Drugmakers' Differences: Analyst's Toolkit - at TheStreet.com | |
| UPDATE: FDA Warns Doctors On Using Plavix With Heartburn Meds - Dow Jones | |
| FDA:Doctors Should Avoid Using Heartburn Medicines With Plavix - Dow Jones | |
| A Big Upgrade for Sanofi-Aventis - MotleyFool.com | |
| Trading Overview for Poniard Pharmaceuticals Inc. Issued by Beacon Equity - GlobeNewswire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 62.31 | -0.12 / -0.19% | 13.60 |
| PFE | Pfizer Inc | 18.36 | 0.25 / 1.38% | 15.43 |
| NVS | Novartis AG | 53.13 | -0.16 / -0.30% | 14.92 |
Short Interest Date:
Oct 30 2009
Short Interest Shares:
2,948,924
Short Interest Ratio:
1.7
Float:
n/a
Short Interest as a % of Float:
n/a
Average Daily Volume:
2,021,400
Outstanding Shares:
2,631,116,430
Sanofi-aventis was incorporated under the laws of France in 1994. It is a global pharmaceutical group, which is engaged in the research, development, manufacture and marketing of healthcare products. Its business includes two main activities: pharmaceuticals and human vaccines through sanofi ... (more)
| 2008 Revenue: | $40.1 B | Headquarters: Paris, |
| Employees: | 98,213 | CEO: Christopher Viehbacher |
| Net Income: | $6.0 B | Industry: Pharmaceuticals |
| Market Cap: | $99.1 B | Website: www.sanofi-aventis.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| SNY | 37.67 | -0.01 / -0.03% | 37.68 | 37.69 | 37.11 | Profile Chart News |
© 2009 Cable News Network. A Time Warner Company. All Rights Reserved.
Terms under which this service is provided to you. Privacy Policy
Live Quotes automatically refresh, but individual equities are delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
* : Time reflects local markets trading time. † - Intraday data delayed 15 minutes for Nasdaq, and 20 minutes for other exchanges. Disclaimer
| Copyright © 2009 BigCharts.com Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc. Intraday data provided by Interactive Data Real-Time Services and subject to the Terms of Use. Intraday data is at least 20-minutes delayed. All times are ET. Historical, current end-of-day data, and splits data provided by Interactive Data Pricing and Reference Data. Fundamental data provided by Morningstar, Inc.. SEC Filings data provided by Edgar Online Inc.. Earnings data provided by FactSet CallStreet, LLC. |
